Multiparametric Magnetic Resonance Imaging, Autoimmune Hepatitis, and Prediction of Disease Activity
Katherine Arndtz, Elizabeth Shumbayawonda, James Hodson, Peter J. Eddowes, Andrea Dennis, Helena Thomaides‐Brears, Sofia Mouchti, Matt D. Kelly, Rajarshi Banerjee, Stefan Neubauer, Gideon M. Hirschfield – 22 February 2021 – Noninvasive monitoring of disease activity in autoimmune hepatitis (AIH) has potential advantages for patients for whom liver biopsy is invasive and with risk. We sought to understand the association of multiparametric magnetic resonance imaging (mpMRI) with clinical course of patients with AIH.